Rabbit Polyclonal UBE2I / UBC9 antibody. Suitable for IHC-P, IP, ICC/IF, WB and reacts with Human, Mouse, Rat samples. Cited in 16 publications.
View Alternative Names
UBC9, UBCE9, UBE2I, SUMO-conjugating enzyme UBC9, RING-type E3 SUMO transferase UBC9, SUMO-protein ligase, Ubiquitin carrier protein 9, Ubiquitin carrier protein I, Ubiquitin-conjugating enzyme E2 I, Ubiquitin-protein ligase I, p18
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-UBE2I / UBC9 antibody (AB33044)
ICC/IF image of ab33044 stained human HeLa cells. The cells were PFA fixed (10 min), permabilised in TBS-T (20 min) and incubated with the antibody (ab33044, 1μg/ml) for 1h at room temperature. 1%BSA / 10% normal goat serum / 0.3M glycine was used to quench autofluorescence and block non-specific protein-protein interactions. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red). DAPI was used to stain the cell nuclei (blue).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UBE2I / UBC9 antibody (AB33044)
IHC image of ab33044 staining UBE2I / UBC9 in Human kidney formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab33044, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- IP
Unknown
Immunoprecipitation - Anti-UBE2I / UBC9 antibody (AB33044)
UBE2I / UBC9 was immunoprecipitated using 0.5mg Hela whole cell extract, 5µg of Rabbit polyclonal to UBE2I / UBC9 and 50µl of protein G magnetic beads (+). No antibody was added to the control (-).
The antibody was incubated under agitation with Protein G beads for 10min, Hela whole cell extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
Proteins were eluted by addition of 40µl SDS loading buffer and incubated for 10min at 70oC; 10µl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab33044.
Secondary : Clean blot (HRP conjugate) at 1/1000 dilution.
Band : 18kDa : UBE2I / UBC9.
All lanes:
Immunoprecipitation - Anti-UBE2I / UBC9 antibody (ab33044)
Predicted band size: 18 kDa
false
- WB
Project
Western blot - Anti-UBE2I / UBC9 antibody (AB33044)
All lanes:
Western blot - Anti-UBE2I / UBC9 antibody (ab33044) at 1 µg/mL
Lane 1:
HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 20 µg
Lane 2:
Western blot - Jurkat whole cell lysate (<a href='/en-us/products/cell-lysates/jurkat-whole-cell-lysate-ab7899'>ab7899</a>) at 20 µg
Lane 3:
Western blot - A-431 whole cell lysate (<a href='/en-us/products/cell-lysates/a-431-whole-cell-lysate-ab7909'>ab7909</a>) at 20 µg
Secondary
All lanes:
IR Dye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/15000 dilution
Predicted band size: 18 kDa
Observed band size: 18 kDa
false
- WB
Project
Western blot - Anti-UBE2I / UBC9 antibody (AB33044)
All lanes:
Western blot - Anti-UBE2I / UBC9 antibody (ab33044) at 1 µg/mL
Lane 1:
Western blot - NIH/3T3 whole cell lysate (<a href='/en-us/products/cell-lysates/nih-3t3-whole-cell-lysate-ab7179'>ab7179</a>) at 10 µg
Lane 2:
MEF1 (Mouse embryonic fibroblast cell line) Whole Cell Lysate at 10 µg
Lane 3:
Testis (Mouse) Tissue Lysate - normal tissue at 10 µg
Lane 4:
PC12 (Rat adrenal pheochromocytoma cell line) Whole Cell Lysate at 10 µg
Secondary
All lanes:
IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/10000 dilution
Predicted band size: 18 kDa
Observed band size: 100 kDa,18 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The SUMO conjugating enzyme UBE2I is part of the SUMOylation complex which includes the SUMO E1 enzyme and SUMO E3 ligase. It facilitates the attachment of SUMO proteins to target proteins which can influence protein stability localization and interaction with other proteins. This modification usually regulates important cellular functions such as transcription DNA repair and cell cycle progression.
Pathways
Proteins modified by UBE2I participate in significant biological pathways such as the DNA damage response and cell cycle regulation. In the DNA damage response UBE2I works with proteins such as p53 and BRCA1 to maintain genomic stability. In cell cycle pathways interactions with proteins like cyclin D1 and CDK inhibitors help control cellular proliferation by SUMOylating key regulatory proteins.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (16)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:21497 PubMed40593246
2025
Applications
Unspecified application
Species
Unspecified reactive species
Alzheimer's & dementia : the journal of the Alzheimer's Association 21:e70030 PubMed40047257
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 15:674 PubMed39277582
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 84:3271-3287.e8 PubMed39178863
2024
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 10:eadn8963 PubMed38838144
2024
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 15: PubMed37766305
2023
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 6:eaaz0361 PubMed32232156
2020
Applications
Unspecified application
Species
Unspecified reactive species
Development (Cambridge, England) 146: PubMed31704792
2019
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular neuroscience 13:486 PubMed31749687
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 75:823-834.e5 PubMed31302001
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com